GILEAD SCIENCES INC. overview

NORTHAMPTON, MA / ACCESSWIRE / April 18, 2024 / Gilead Sciences published its 2023 Environmental, Social and Governance (ESG) Impact Report , which uses the ESG framework to highlight the successes and achievements of the prior year. In this year's report, you will see examples of Gilead's impact across four pillars: Innovating Scientific Solutions Advancing Health Equity and Access Empowering People and Communities Sustaining Our Shared Planet Learn how we're advancing our vision to create a...

NORTHAMPTON, MA / ACCESSWIRE / April 2, 2024 / Women represent more than half of Gilead's workforce, and our weighted salary ratio for women to men globally in 2023 was 99.93:100. We'll continue our efforts to champion an environment of equality and inclusion for all. Gilead Sciences Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care...

NORTHAMPTON, MA / ACCESSWIRE / March 26, 2024 / Dr. Thomas Odeny grew up in rural Kenya during the height of the HIV epidemic in sub-Saharan Africa. After graduating from medical school at the University of Nairobi, he decided to begin his career in HIV care as a way to give back to his community. "My home district had the highest prevalence of HIV in Kenya at the time," says Thomas. "I had one brother living with HIV and one who died from it, so I felt this is where I was needed." Thomas...

NORTHAMPTON, MA / ACCESSWIRE / March 19, 2024 / Gilead Sciences: In the summer of 2019, Bora was celebrating his mother's birthday at a seaside restaurant in Istanbul when he suddenly became very ill and couldn't finish his meal. "I woke up the next day with a high fever and terrible pain and was unable to move or eat for 10 days," recalls Bora. It was at this point that a friend took him to an anonymous HIV testing clinic. After losing a close friend to an HIV-related condition years earlier,...

NORTHAMPTON, MA / ACCESSWIRE / March 12, 2024 / We're committed to increasing diverse representation in clinical trials, especially for those who have been historically underrepresented. Our 2024 Toward Health Equity Oncology Grant focuses on inclusion in trials and supports the mission of 36 global organizations centered on a common goal: providing quality, accessible healthcare for people living with cancer. https://gilead.inc/3OTUpuh Gilead Sciences Gilead Sciences, Inc. is a research-based...

NORTHAMPTON, MA / ACCESSWIRE / March 7, 2024 / Gilead Sciences For many people living with cancer, hearing about the experiences of others can be helpful. Dale, who is living with breast cancer, shares her journey and point of view about how sharing information can help reduce health disparities. Gilead Sciences Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives...

NORTHAMPTON, MA / ACCESSWIRE / March 5, 2024 / Gilead Sciences Originally published by SAN FRANCISCO BUSINESS TIMES on bizjournals.com Much has changed since Daniel O'Day, chairman and CEO, arrived at Gilead Sciences in 2019. The company has grown considerably and expanded on its long-standing leadership in antiviral therapies to include a focus on cancer medicines. Today the Foster City-based company is the second-largest biotech employer in the Bay Area, and according to a Bay Area Council...

NORTHAMPTON, MA / ACCESSWIRE / February 29, 2024 / This year's theme for National Black HIV/AIDS Awareness Day is "Engage, Educate, Empower: Uniting to End HIV/AIDS in Black Communities." We spoke with C. Virginia Fields, President and CEO of National Black Leadership Commission on Health (Black Health), a Gilead grantee, about how together, we can take action toward meaningful change. We commend Virginia and our many community partners for continuing to honor and advance the decades of progress...